DeLuca Teresa purchased $144K of SGRY

DeLuca Teresa purchased 10,000 shares of Surgery Partners, Inc. (SGRY) at $14.35 ($0.14M total) on 2026-08-18.

Original reporting
SEC EDGAR · DeLuca Teresa
Published Aug 19, 2026, 8:17 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 8:24 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SGRY
Bullish
medium confidence
Mentioned
$SGRY
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SGRYBullishLow
01

Why it matters

The director's purchase adds a modest bullish signal but is unlikely to move the stock significantly.

02

Market read

Insider buying is a positive indicator but the modest size limits market impact.

03

What to watch

The transaction size is small relative to overall float; no immediate catalyst beyond the filing.

Relevance 5/10Novelty 5/10Timing: transaction dated 2026-08-18, reported on 2026-08-19

Background

Form 4 filings disclose insider transactions and are primary sources of new information.

Company-level read

Ticker impact

$SGRYBullishMedium confidence
Context

Director Teresa DeLuca purchased 10,000 shares of Surgery Partners for $143,500, increasing her stake to 66,843 shares.

Expected impact

Modest upside pressure as the market digests the insider purchase.

Evidence & confidence

The purchase size is modest relative to the company's market cap, but insider buying is generally viewed favorably.

Market effects

Minimal impact on the healthcare services sector.

Limited to U.S. markets where the stock trades.

Low

Counterpoint

The purchase may be routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Surgery Partners, Inc.

    Provider of outpatient surgery facilities.

  • Teresa DeLuca

    Director of Surgery Partners.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SGRYMed

Surgery Partners: Q3 Earnings Snapshot

Surgery Partners Inc. (SGRY) reported a Q3 loss of $21.1 million, or 16 cents per share, with adjusted earnings of 16 cents per share. The company's revenue was $815.3 million. The Tennessee-based surgical facilities operator provided these financial results on Monday.

$SGRYHighAI 8/10

SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS

Surgery Partners, Inc. (SGRY) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 SURGERY PARTNERS, INC. ANNOUNCES THIRD QUARTER 2026 RESULTS BRENTWOOD, Tenn., November 9, 2026 (GLOBE NEWSWIRE) - Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator, today announced re